atopic dermatitis
Conditions
Interventions
Spleen deficiency and blood dryness syndrome group:Jianpi Runfu Decoction and other prescriptions are added or subtracted, decocted and taken in water, one dose a day, and taken in two warm doses, 200
Spleen deficiency and dampness accumulation syndrome group:Shenling Baizhu powder, Xiaoer Huashi Decoction and other prescriptions were added or subtracted. They were decocted and taken in water, one
Other types of syndrome groups:TPC
Rheumatic heat accumulation syndrome group:Xiaofeng powder and other prescriptions were added or subtracted, decocted and taken in water, one dose a day, and taken in two warm doses, 200ml each time.
Spleen kidney yang deficiency syndrome group:Zhenwu decoction or Wuling powder and other prescriptions are added or subtracted, decocted and taken in water, 1 dose a day, and taken twice, 200ml each t
Heart fire spleen deficiency syndrome group:Peitu Qingxin Decoction and other prescriptions were added or subtracted decocted and taken in water one dose a day and taken in two warm doses 200ml each t
Heart spleen heat accumulation syndrome group:Sanxin Daochi Decoction and other prescriptions are added or subtracted, decocted and taken in water, 1 dose a day, and taken in two warm doses, 200ml eac
Sponsors
Shanghai Skin Diseases Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1: Sign the informed consent form and voluntarily participate in this study. 2: Gender is not limited age 18 and above. 3: Diagnosed with atopic dermatitis. 4: SCORAD score = 25 points. 5: Previously received Western medicine treatment but not traditional Chinese medicine treatment.
Exclusion criteria
Exclusion criteria: 1: Pregnant or lactating women. 2: Abnormal liver and kidney function as well as blood system function. 3: Previously completed or withdrawn from this study. 4: Currently participating in research on other atopic dermatitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EASI score decreased by 50% from baseline to 16 weeks (EASI50); | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS;ADCT;POEM;DLQI;BSA;EASI;TCM Syndrome Scale;IGA; | — |
Countries
China
Contacts
Public ContactBin Li
Shanghai Skin Diseases Hospital
Outcome results
None listed